A leading provider of kidney dialysis services in the United States, operating outpatient dialysis centers and providing related lab services. Investors monitor its performance due to its dominant market position and exposure to healthcare reimbursement trends.
3 members of Congress have disclosed 9 trades in DaVita Inc. (DVA), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 3 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2012-01-11 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2012-01-11 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2012-01-01 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2011-06-10 | MICHAEL T. MCCAUL | buy | — |
| 2011-06-10 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2011-06-10 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2011-03-09 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2007-07-09 | F. JAMES SENSENBRENNER | buy | $11,142.00 |
| 2003-05-10 | JAMES B. RENACCI | buy | $1,216.45 |